Tissue Engineering
Researchers from Cornell University report details of new studies and findings in the area of tissue engineering
Published in Blood Weekly, March 6th, 2008
New research, 'Binding mechanisms of PEGylated ligands reveal multiple effects of the PEG scaffold,' is the subject of a report. According to recent research published in the journal Biochemistry, "A series of synthetic ligands consisting of poly(ethylene glycol) (PEG), capped on one or both ends with the hapten 2,4-dinitrophenyl (DNP), were previously shown to be potent inhibitors of cellular activation in RBL mast cells stimulated by a multivalent antigen [Baird, E. J., Holowka, D., Coates, G."
"W., and Baird, B. (2003) Biochemistry 42, 12739-12748]. In this study, we systematically investigated the effect of increasing length of the PEG scaffold on the binding...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
Source: Blood Weekly (2008-03-06)
More Articles from Blood Weekly
- Acidosis
Research in the area of acidosis reported from Maulana Azad Medical College, Medical College - Anapol, Schwartz, Weiss, Cohan, Feldman & Smalley
Anapol Schwartz Attorney Representing Trasylol(R) Victims Says Medical Study - Confirming Heart Bypass Drug Mortality Risk - to Open Floodgates for More Litigation - Breast Cancer
Abviva Announces Patent Issuance for Core Technology Used in Mammastatin Serum Assay Diagnostic Test for Breast Cancer - Cancer
Plexxikon Announces Publication of Key Data Demonstrating Possible Personalized Medicine for a Variety of Cancers - Dengue Fever
Reports outline dengue fever study findings from M.T. Cordeiro and colleagues - Dengue Fever
Studies from University of Rochester yield new information about dengue fever - More from this issue of Blood Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
